19 research outputs found

    Alteration of Bcl11b upon stimulation of both MAP Kinase- and Gsk3-dependent signaling pathways in double negative thymocytes

    Get PDF
    Bcl11b is a transcription factor critical for thymocyte development. We previously characterized the kinetic post-translational modifications (PTMs) of Bcl11b in double positive (DP) thymocytes during stimulation of the T cell receptor-activated MAP kinase pathway. However, the PTMs of Bcl11b in thymocytes from other developmental stages in the thymus, primarily double negative (DN) cells, have not been previously identified. We found that kinetic modifications of Bcl11b in DN cells are somewhat different than the patterns observed in DP cells. Distinct from DP thymocytes, phosphorylation and sumoylation of Bcl11b in DN cells were not oppositely regulated in response to activation of MAP kinase, even though hyper-phosphorylation of Bcl11b coincided with near complete desumoylation. Additionally, prolonged stimulation of the MAP kinase pathway in DN cells, unlike DP thymocytes, did not alter Bcl11b levels of sumoylation or ubiquitinylation, or stability. On the other hand, activation of Wnt/Gsk3-dependent signaling in DN cells resulted in composite dephosphorylation and sumoylation of Bcl11b. Moreover, stimulation of MAP kinase and/or Wnt signaling pathways differentially affects gene expression of some Bcl11b target and maturation- associated genes. Defining the signaling pathways and regulation of sequence-specific transcription factors (SSTFs) by PTMs at various stages of thymopoiesis may improve our understanding of leukemogenesis.The accepted manuscript in pdf format is listed with the files at the bottom of this page. The presentation of the authors' names and (or) special characters in the title of the manuscript may differ slightly between what is listed on this page and what is listed in the pdf file of the accepted manuscript; that in the pdf file of the accepted manuscript is what was submitted by the author

    Rx for Joy: Boosting Wellbeing and Fulfillment in Oncology Pharmacist Work

    No full text
    The October 2024 Better U Survey revealed that only 27% of oncology pharmacists felt energized and showed no signs of burnout, which is significantly lower than the University of Utah\u27s clinical team average of 45%. This project\u27s goal is to increase this rate by 5% by the Fall 2025 survey. To address this, using the IHI framework, we conducted What Matters to You? (WMTY) conversations with oncology pharmacists from three distinct groups and collected "bright spots‚" and "stops" using sticky notes. Feedback highlighted daily improvements, participative management, and camaraderie as key factors contributing to workplace challenges. We identified different needs across groups and established the foundation for projects targeting the disease state groups. Bone Marrow Transplant: Improved coordination of outside labs; Hematology: Improved coordination of oral chemotherapy refills; Medical Oncology: Organizing team potlucks. Our success can be attributed to early pharmacy management support, preparing teams with a project pitch, customizing interventions to specific teams, maintaining anonymity, and gaining provider and nursing leadership support. To ensure lasting improvements, we will ensure our chosen projects are executed by checking in regularly with the teams. We also will continue annual WMTY conversations to reassess team needs and continue participation in joy-in-work training. Citation: Perlo J, Balik B, Swensen S, Kabcenell A, Landsman J, Feeley D. IHI Framework for Improving Joy in Work. Cambridge, MA: Institute for Healthcare Improvement, 2017

    The Methylerythritol Phosphate Pathway Contributes to Carotenoid But Not Phytol Biosynthesis in <i>Euglena </i><i>g</i><i>racilis</i>

    No full text
    The biosynthesis of diadinoxanthin and β-carotene in Euglena gracilis was examined using [1-13C]-d-glucose and [5,5-2H2]-1-deoxy-d-xylulose. In contrast to previous studies on isoprenoid biosynthesis in E. gracilis, the results demonstrate a role for the methylerythritol phosphate (MEP) pathway, along with the mevalonate pathway, in carotenoid biosynthesis. Interestingly, the MEP pathway is not involved in the biosynthesis of phytol, a result not previously observed for other chloroplast-containing organisms
    corecore